<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl13444</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-13444</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая эндокринология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical endocrinology</subject></subj-group></article-categories><title-group><article-title>Уровень продукции активных форм кислорода в моноцитах периферической крови у пациентов с болезнью Грейвса в динамике после радионуклидного лечения</article-title><trans-title-group xml:lang="en"><trans-title>Level of reactive oxygen species production in peripheral blood monocytes in patients with Graves’ disease after radioiodine therapy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6341-7810</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фомина</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fomina</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фомина Дарья Викторовна </p><p>660022, Красноярск, ул. Партизана Железняка, д. 1 </p></bio><bio xml:lang="en"><p>Daria V. Fomina </p><p>660022, Krasnoyarsk, Partizana Zheleznyka str., 1</p></bio><email xlink:type="simple">fominad@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1709-466X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Догадин</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dogadin</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Догадин Сергей Анатольевич, д.м.н., профессор </p><p>Красноярск </p></bio><bio xml:lang="en"><p>Sergey A. Dogadin, MD, PhD, Professor </p><p>Krasnoyarsk </p></bio><email xlink:type="simple">sadogadin@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5829-672X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савченко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savchenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Савченко Андрей Анатольевич, д.м.н., профессор  </p><p>Красноярск </p></bio><bio xml:lang="en"><p>Andrei A. Savchenko, MD, PhD, Professor </p><p>Krasnoyarsk </p></bio><email xlink:type="simple">aasavchenko@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1041-9871</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гвоздев</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Gvozdev</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гвоздев Иван Игоревич  </p><p>Красноярск </p></bio><bio xml:lang="en"><p>Ivan I. Gvozdev </p><p>Krasnoyarsk </p></bio><email xlink:type="simple">leshman-mult@mail.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Красноярский государственный медицинский университет им. профессора В.Ф. Войно-Ясенецкого</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnoyarsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Красноярский государственный медицинский университет им. профессора В.Ф. Войно-Ясенецкого; Краевая клиническая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnoyarsk State Medical University; Krasnoyarsk regional clinical hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Красноярский государственный медицинский университет им. профессора В.Ф. Войно-Ясенецкого; Красноярский научный центр Сибирского отделения Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center «Krasnoyarsk Science Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Красноярский научный центр Сибирского отделения Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center «Krasnoyarsk Science Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>05</month><year>2025</year></pub-date><volume>71</volume><issue>2</issue><fpage>14</fpage><lpage>21</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Фомина Д.В., Догадин С.А., Савченко А.А., Гвоздев И.И., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Фомина Д.В., Догадин С.А., Савченко А.А., Гвоздев И.И.</copyright-holder><copyright-holder xml:lang="en">Fomina D.V., Dogadin S.A., Savchenko A.A., Gvozdev I.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/13444">https://www.probl-endojournals.ru/jour/article/view/13444</self-uri><abstract><sec><title>ОБОСНОВАНИЕ</title><p>ОБОСНОВАНИЕ. Аутоиммунные заболевания, такие как болезнь Грейвса, являются сложными патологиями, часто требующими интенсивного и длительного лечения. Однако механизмы, способствующие развитию и поддержанию этой патологии, до сих пор остаются не до конца изученными. Понимание роли врожденного иммунного ответа, особенно в контексте реакций моноцитов, в развитии болезни Грейвса остается малоизученным аспектом.</p></sec><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ. Изучить уровень продукции активных форм кислорода (АФК) в моноцитах у пациентов с болезнью Грейвса после радиойодтерапии (РЙТ) для выявления уровня активации макрофагально-моноцитарной системы.</p></sec><sec><title>МАТЕРИАЛЫ И МЕТОДЫ</title><p>МАТЕРИАЛЫ И МЕТОДЫ. В исследование включено 48 пациенток с болезнью Грейвса возрастом от 18 до 65 лет. Гормональный статус и активность моноцитов анализировали до и через 1, 3 и 6 месяцев после радионуклидного лечения. Уровень АФК определяли с помощью хемилюминесценции спонтанной и индуцированной люминолом и люцегинином.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. У пациентов с болезнью Грейвса выявлено снижение уровня синтеза АФК в моноцитах по сравнению с контрольной группой. Эти изменения наблюдались как до, так и после радионуклидного лечения. Показано, что изменения в производстве АФК не зависят от тиреоидной функции и уровня аутоантител. Снижение продукции также отмечено в отношении вторичных АФК в моноцитах.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. Изменения свидетельствуют о потенциальном иммуносупрессивном воздействии радионуклидного лечения и его влиянии на активность НАДФН-оксидазы моноцитов. Низкий уровень синтеза АФК коррелирует с ингибированием аутоиммунного процесса и снижением активации макрофагально-моноцитарной системы. Исследование подтверждает важность роли моноцитов в системе продукции АФК и их влияние на аутоиммунный процесс при болезни Грейвса. Эти результаты могут иметь клиническую значимость и способствовать разработке новых иммунотропных стратегий для лечения данного заболевания.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>BACKGROUND</title><p>BACKGROUND: Autoimmune diseases such as Graves’ disease are complex pathologies that often require intensive and long-term treatment. However, the mechanisms contributing to the development and maintenance of this pathology are still not fully understood. Understanding the role of the innate immune response, especially in the context of monocytes, in the development of Graves’ disease remains a poorly understood aspect.</p></sec><sec><title>AIM</title><p>AIM: To study the level of ROS production in monocytes in patients with Graves’ disease after RAI to identify the level of activation of the macrophage-monocyte system.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: The hormonal status and monocyte activity were analyzed before and 1, 3 and 6 months after RAI. The level of ROS was determined using spontaneous and luminol- and luceginin-derived chemiluminescence.</p></sec><sec><title>RESULTS</title><p>RESULTS: The study included 48 patients with Graves’ disease, aged from 18 to 65 years. In patients with Graves’ disease, a decrease in the intensity of free radical processes in monocytes was detected compared to the control group. These changes were observed both before and after RAI. It has been shown that changes in ROS production are independent of thyroid function and antibody levels. The changes indicate the potential immunosuppressive effects of radionuclide treatment and its effect on monocyte NADPH oxidase activity. A decrease in the production of secondary ROS in monocytes was also noted, which may indicate a decrease in the activation of monocytes during antigenic stimulation and inhibition of autoimmune processes.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: Reduced metabolic activity of monocytes and low levels of ROS synthesis correlate with inhibition of the autoimmune process and decreased activation of the macrophage-monocyte system. The study confirms the importance of the role of monocytes in the ROS production system and their influence on the autoimmune process in Graves’ disease. These results may have clinical significance and contribute to the development of new immunotropic strategies for the treatment of this disease.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>болезнь Грейвса</kwd><kwd>моноциты</kwd><kwd>АФК</kwd><kwd>активные формы кислорода</kwd><kwd>хемилюминесценция</kwd><kwd>радиойодтерапия</kwd><kwd>РЙТ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Graves’ disease</kwd><kwd>monocytes</kwd><kwd>ROS</kwd><kwd>Reactive oxygen species</kwd><kwd>chemiluminescence</kwd><kwd>RAI</kwd><kwd>radioactive iodine</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнялось на базе лаборатории молекулярно-клеточной физиологии и патологии Федерального исследовательского центра «Красноярский научный центр Сибирского отделения Российской академии наук», обособленное подразделение «НИИ медицинских проблем Севера».</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Davies TF, Andersen S, Latif R, et al. Graves’ disease. Nat Rev Dis Primers. 2020;6(1):52. doi: https://doi.org/10.1038/s41572-020-0184-y</mixed-citation><mixed-citation xml:lang="en">Davies TF, Andersen S, Latif R, et al. Graves’ disease. Nat Rev Dis Primers. 2020;6(1):52. doi: https://doi.org/10.1038/s41572-020-0184-y</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lichiardopol C, Moţa M. The thyroid and autoimmunity. Rom J Intern Med. 2009;47(3):207-15</mixed-citation><mixed-citation xml:lang="en">Lichiardopol C, Moţa M. The thyroid and autoimmunity. Rom J Intern Med. 2009;47(3):207-15</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Nurieva RI, Chung Y, Hwang D, et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity. 2008;29(1):138-49. doi: https://doi.org/10.1016/j.immuni.2008.05.009</mixed-citation><mixed-citation xml:lang="en">Nurieva RI, Chung Y, Hwang D, et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity. 2008;29(1):138-49. doi: https://doi.org/10.1016/j.immuni.2008.05.009</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu C, Ma J, Liu Y et al. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 2012;97(3):943-50. doi: https://doi.org/10.1210/jc.2011-2003</mixed-citation><mixed-citation xml:lang="en">Zhu C, Ma J, Liu Y et al. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 2012;97(3):943-50. doi: https://doi.org/10.1210/jc.2011-2003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ożańska A, Szymczak D, Rybka J. Pattern of human monocyte subpopulations in health and disease. Scand J Immunol. 2020;92(1):e12883. doi: https://doi.org/10.1111/sji.12883</mixed-citation><mixed-citation xml:lang="en">Ożańska A, Szymczak D, Rybka J. Pattern of human monocyte subpopulations in health and disease. Scand J Immunol. 2020;92(1):e12883. doi: https://doi.org/10.1111/sji.12883</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sedeek M, Nasrallah R, Touyz RM, Hébert RL. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol. 2013;24(10):1512-8. doi: https://doi.org/10.1681/ASN.2012111112</mixed-citation><mixed-citation xml:lang="en">Sedeek M, Nasrallah R, Touyz RM, Hébert RL. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol. 2013;24(10):1512-8. doi: https://doi.org/10.1681/ASN.2012111112</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mseddi M, Ben Mansour R, Gargouri B, et al. Proteins oxidation and autoantibodies’ reactivity against hydrogen peroxide and malondialdehyde -oxidized thyroid antigens in patients’ plasmas with Graves’ disease and Hashimoto Thyroiditis. Chem Biol Interact. 2017;272:145-152. doi: https://doi.org/10.1016/j.cbi.2017.04.013</mixed-citation><mixed-citation xml:lang="en">Mseddi M, Ben Mansour R, Gargouri B, et al. Proteins oxidation and autoantibodies’ reactivity against hydrogen peroxide and malondialdehyde -oxidized thyroid antigens in patients’ plasmas with Graves’ disease and Hashimoto Thyroiditis. Chem Biol Interact. 2017;272:145-152. doi: https://doi.org/10.1016/j.cbi.2017.04.013</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Трошина Е.А., Свириденко Н.Ю., Ванушко В.Э., и др. Федеральные клинические рекомендации Российской ассоциации эндокринологов по диагностике и лечению токсического зоба. // Клиническая и экспериментальная тиреоидология. — 2014. — Т.10. — №3. — С.8-19. doi: https://doi.org/10.14341/ket201438-19</mixed-citation><mixed-citation xml:lang="en">Troshina EA, Sviridenko NYu, Vanushko VE, et al. Russian Association of Endocrinologists clinical practice guidelines for thyrotoxicosis diagnosis and treatment. Clinical and experimental thyroidology. 2014;10(3):8-19. (In Russ.) doi: https://doi.org/10.14341/ket201438-19</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Diana T, Daiber A, Oelze M, et al. Stimulatory TSHReceptor Antibodies and Oxidative Stress in Graves Disease. J Clin Endocrinol Metab. 2018;103(10):3668-3677. doi: https://doi.org/10.1210/jc.2018-00509</mixed-citation><mixed-citation xml:lang="en">Diana T, Daiber A, Oelze M, et al. Stimulatory TSHReceptor Antibodies and Oxidative Stress in Graves Disease. J Clin Endocrinol Metab. 2018;103(10):3668-3677. doi: https://doi.org/10.1210/jc.2018-00509</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Догадин C.А., Дудина М.А., Савченко А.А., и др. Активность респираторного взрыва нейтрофильных гранулоцитов крови в дебюте болезни Грейвса. // Проблемы Эндокринологии. — 2017. — Т.63. — №1. — С.4-8. doi: https://doi.org/10.14341/probl20176314-8</mixed-citation><mixed-citation xml:lang="en">Dogadin SA, Dudina MA, Savchenko AA, et al. The respiratory explosion activity of neutrophils in blood from patients with Graves’ disease manifestation. Problems of Endocrinology. 2017;63(1):4-8. (in Russ.) doi: https://doi.org/10.14341/probl20176314-8</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ma WT, Chang C, Gershwin ME, Lian ZX. J Autoimmun. 2017;83:95- 112. doi: https://doi.org/10.1016/j.jaut.2017.07.003.</mixed-citation><mixed-citation xml:lang="en">Ma WT, Chang C, Gershwin ME, Lian ZX. J Autoimmun. 2017;83:95- 112. doi: https://doi.org/10.1016/j.jaut.2017.07.003.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X, Wang Y, Qi Y, et al. Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves’ disease. Sci Rep. 2021;11(1):13443. doi: https://doi.org/10.1038/s41598-021-92737-4</mixed-citation><mixed-citation xml:lang="en">Chen X, Wang Y, Qi Y, et al. Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves’ disease. Sci Rep. 2021;11(1):13443. doi: https://doi.org/10.1038/s41598-021-92737-4</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">González A, Calleja A, Santiago E, et al. Correlation of activated monocytes or B cells with T lymphocyte subsets in patients with Graves’ disease. Int J Mol Med. 1998;1(1):95-103</mixed-citation><mixed-citation xml:lang="en">González A, Calleja A, Santiago E, et al. Correlation of activated monocytes or B cells with T lymphocyte subsets in patients with Graves’ disease. Int J Mol Med. 1998;1(1):95-103</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">López-Moratalla N, Calleja A, González A, et al. Inducible nitric oxide synthase in monocytes from patients with Graves’ disease. Biochem Biophys Res Commun. 1996;226(3):723-9. doi: https://doi.org/10.1006/bbrc.1996.1420</mixed-citation><mixed-citation xml:lang="en">López-Moratalla N, Calleja A, González A, et al. Inducible nitric oxide synthase in monocytes from patients with Graves’ disease. Biochem Biophys Res Commun. 1996;226(3):723-9. doi: https://doi.org/10.1006/bbrc.1996.1420</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Pautz A, Art J, Hahn S, et al. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010;23(2):75-93. doi: https://doi.org/10.1016/j.niox.2010.04.007</mixed-citation><mixed-citation xml:lang="en">Pautz A, Art J, Hahn S, et al. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010;23(2):75-93. doi: https://doi.org/10.1016/j.niox.2010.04.007</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Weerd K, Van Hagen PM, Schrijver B, et al. The peripheral blood compartment in patients with Graves’ disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes. Clin Exp Immunol. 2013;174(2):256-64. doi: https://doi.org/10.1111/cei.12183</mixed-citation><mixed-citation xml:lang="en">Van der Weerd K, Van Hagen PM, Schrijver B, et al. The peripheral blood compartment in patients with Graves’ disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes. Clin Exp Immunol. 2013;174(2):256-64. doi: https://doi.org/10.1111/cei.12183</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
